Manager × security

PERCEPTIVE ADVISORS LLC RYTM holdings history

Who else holds this security? →

RHYTHM PHARMACEUTICALS INC · CUSIP 76243J105 · CIK 1224962

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, PERCEPTIVE ADVISORS LLC reported 2.59M RYTM (shares), valued at $287.16M, or 4.46% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
4.46%
Shares
2.59M
2,586,295
Reported value
$287.16M
USD

Shares increased 8.95%; reported value increased 39.09%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20264.46%2,586,295SEC filing ↗Filed Aug 14, 2026
Q1 20264.08%2,373,795SEC filing ↗Filed May 29, 2026Amended
Q4 20254.99%2,546,391SEC filing ↗Filed Feb 17, 2026
Q3 20258.33%419,104,969SEC filing ↗Filed Nov 14, 2025
Q2 20255.73%2,418,299SEC filing ↗Filed Aug 14, 2025
Q1 20254.79%2,548,445SEC filing ↗Filed Aug 6, 2025Amended
Q4 20245.74%3,680,473SEC filing ↗Filed Feb 14, 2025
Q3 20244.00%3,560,214SEC filing ↗Filed Nov 14, 2024
Q2 20243.42%3,446,579SEC filing ↗Filed Aug 16, 2024Amended
Q1 20242.50%3,268,579SEC filing ↗Filed Aug 6, 2024Amended
Q4 20232.21%2,154,110SEC filing ↗Filed Feb 26, 2024Amended
Q3 20230.29%380,828SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.29%380,828$8.73MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20232.21%2,154,110$99.02MShares increased 465.64%; reported value increased 1034.24%, and weight changed +1.92 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 26, 2024
Q1 20242.50%3,268,579$141.63MShares increased 51.74%; reported value increased 43.02%, and weight changed +0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2024
Q2 20243.42%3,446,579$141.52MShares increased 5.45%; reported value decreased 0.08%, and weight changed +0.92 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 16, 2024
Q3 20244.00%3,560,214$186.52MShares increased 3.30%; reported value increased 31.80%, and weight changed +0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20245.74%3,680,473$206.03MShares increased 3.38%; reported value increased 10.46%, and weight changed +1.74 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20254.79%2,548,445$134.99MShares decreased 30.76%; reported value decreased 34.48%, and weight changed -0.95 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 6, 2025
Q2 20255.73%2,418,299$152.81MShares decreased 5.11%; reported value increased 13.20%, and weight changed +0.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20258.33%419,104,969$288.39MShares increased 17230.57%; reported value increased 88.72%, and weight changed +2.60 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20254.99%2,546,391$272.57MShares decreased 99.39%; reported value decreased 5.49%, and weight changed -3.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20264.08%2,373,795$206.45MShares decreased 6.78%; reported value decreased 24.26%, and weight changed -0.91 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 29, 2026
Q2 20264.46%2,586,295$287.16MShares increased 8.95%; reported value increased 39.09%, and weight changed +0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
PERCEPTIVE ADVISORS LLC · RHYTHM PHARMACEUTICALS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1224962","quarter":"2026Q2","cusip":"76243J105"}

get_institutional_manager_history
{"cik":"1224962","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.